Susquehanna International Group, LLP Cerus Corp Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1.7 - $2.39 $3,740 - $5,258	2,200 Added 7.41%	31,900 $55,000
Q2 2024 Aug 15, 2024	BUY	$1.62 - $2.04 $1,458 - $1,836	900 Added 3.13%	29,700 $52,000
Q1 2024 May 07, 2024	BUY	$1.66 - $2.42 $20,750 - $30,250	12,500 Added 76.69%	28,800 $54,000
Q4 2023 Feb 14, 2024	SELL	$1.25 - $2.35 $4,250 - $7,990	-3,400 Reduced 17.26%	16,300 $35,000
Q3 2023 Nov 14, 2023	BUY	$1.5 - $3.07 $7,050 - $14,429	4,700 Added 31.33%	19,700 $31,000
Q2 2023 Aug 11, 2023	BUY	$1.79 - $2.9 $3,043 - $4,930	1,700 Added 12.78%	15,000 $36,000
Q1 2023 May 16, 2023	SELL	$2.65 - $3.81 $165,625 - $238,125	-62,500 Reduced 82.45%	13,300 $39,000
Q4 2022 Feb 14, 2023	SELL	$3.38 - $4.22 $777,400 - $970,600	-230,000 Reduced 75.21%	75,800 $276,000
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.83 $149,205 - $253,605	43,500 Added 16.58%	305,800 $1.1 Million

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $305M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.